mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |